JP2015520378A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520378A5
JP2015520378A5 JP2015514216A JP2015514216A JP2015520378A5 JP 2015520378 A5 JP2015520378 A5 JP 2015520378A5 JP 2015514216 A JP2015514216 A JP 2015514216A JP 2015514216 A JP2015514216 A JP 2015514216A JP 2015520378 A5 JP2015520378 A5 JP 2015520378A5
Authority
JP
Japan
Prior art keywords
cell
therapy
central memory
sample
cd45ro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015514216A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520378A (ja
JP6312332B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/042627 external-priority patent/WO2013177505A1/en
Publication of JP2015520378A publication Critical patent/JP2015520378A/ja
Publication of JP2015520378A5 publication Critical patent/JP2015520378A5/ja
Application granted granted Critical
Publication of JP6312332B2 publication Critical patent/JP6312332B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015514216A 2012-05-24 2013-05-24 糖尿病バイオマーカ Active JP6312332B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261651144P 2012-05-24 2012-05-24
US61/651,144 2012-05-24
PCT/US2013/042627 WO2013177505A1 (en) 2012-05-24 2013-05-24 Diabetes biomarkers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018027381A Division JP6761827B2 (ja) 2012-05-24 2018-02-19 糖尿病バイオマーカ

Publications (3)

Publication Number Publication Date
JP2015520378A JP2015520378A (ja) 2015-07-16
JP2015520378A5 true JP2015520378A5 (https=) 2016-11-24
JP6312332B2 JP6312332B2 (ja) 2018-04-18

Family

ID=49621783

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015514216A Active JP6312332B2 (ja) 2012-05-24 2013-05-24 糖尿病バイオマーカ
JP2018027381A Expired - Fee Related JP6761827B2 (ja) 2012-05-24 2018-02-19 糖尿病バイオマーカ
JP2020150183A Pending JP2021001899A (ja) 2012-05-24 2020-09-07 糖尿病バイオマーカ
JP2022175993A Pending JP2023011814A (ja) 2012-05-24 2022-11-02 糖尿病バイオマーカ
JP2024120652A Pending JP2024150702A (ja) 2012-05-24 2024-07-25 糖尿病バイオマーカ

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018027381A Expired - Fee Related JP6761827B2 (ja) 2012-05-24 2018-02-19 糖尿病バイオマーカ
JP2020150183A Pending JP2021001899A (ja) 2012-05-24 2020-09-07 糖尿病バイオマーカ
JP2022175993A Pending JP2023011814A (ja) 2012-05-24 2022-11-02 糖尿病バイオマーカ
JP2024120652A Pending JP2024150702A (ja) 2012-05-24 2024-07-25 糖尿病バイオマーカ

Country Status (13)

Country Link
US (5) US20130316375A1 (https=)
EP (2) EP2856149B1 (https=)
JP (5) JP6312332B2 (https=)
KR (1) KR102172285B1 (https=)
CN (1) CN104520707B (https=)
AU (4) AU2013266145A1 (https=)
CA (1) CA2874507A1 (https=)
DK (1) DK2856149T3 (https=)
ES (1) ES2810227T3 (https=)
IN (1) IN2014DN10259A (https=)
MX (1) MX357169B (https=)
WO (1) WO2013177505A1 (https=)
ZA (1) ZA201409006B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735359B2 (en) 2012-05-24 2014-05-27 Orban Biotech Llc Combinations of modalities for the treatment of diabetes
US20130316375A1 (en) * 2012-05-24 2013-11-28 Orban Biotech Llc Diabetes biomarkers
KR20150033703A (ko) 2012-06-27 2015-04-01 오르반 바이오테크 엘엘씨 당뇨병 치료를 위한 ctla4 융합 단백질
GB2523399B (en) 2014-02-25 2019-03-13 Orban Tihamer A composition comprising ten overlapping peptide fragments of the entire preproinsulin sequence
WO2016103390A1 (ja) * 2014-12-25 2016-06-30 株式会社日立製作所 インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法
CN105567851A (zh) * 2016-02-29 2016-05-11 北京泱深生物信息技术有限公司 一种与糖尿病相关的分子标志物
WO2017162759A1 (en) * 2016-03-22 2017-09-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits of assessing status, risk or prognosis of type 1 diabetes
WO2021260654A1 (en) 2020-06-26 2021-12-30 Phaim Pharma Ltd Psoriasis and other autoimmune diseases antigen immune modulator (aim) therapeutic platform
US20240277768A1 (en) 2021-06-17 2024-08-22 Tihamer Orban Individualized Cell Therapy Using Patient-Derived Antigen-Specific Regulatory T Cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007037544A1 (ja) * 2005-09-30 2009-04-16 国立大学法人京都大学 制御性t細胞の製造を向上させる薬剤のスクリーニング方法の開発、及び免疫抑制性のマクロライド系抗生剤を用いる制御性t細胞の製造方法
WO2009120341A2 (en) * 2008-03-24 2009-10-01 University Of South Florida Biomarkers for predicting response to immunosuppressive therapy
US20100080784A1 (en) * 2008-09-12 2010-04-01 Torrey Pines Institute For Molecular Studies Methods for treating cachexia and lymphopenia
US20130316375A1 (en) * 2012-05-24 2013-11-28 Orban Biotech Llc Diabetes biomarkers
JP7618502B2 (ja) * 2021-05-14 2025-01-21 東京計器株式会社 船舶用自動操舵装置

Similar Documents

Publication Publication Date Title
JP2015520378A5 (https=)
Lo et al. Biomarkers for kidney transplant rejection
Lu et al. NanoVelcro Chip for CTC enumeration in prostate cancer patients
Piroird et al. The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
MX2009013411A (es) Deteccion de antigenos transportados por eritrocitos y de anticuerpos anti-eritrocitos.
Fu et al. Liquid biopsy technologies for hematological diseases
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
AR060120A1 (es) Medio y metodo para diagnosticar la diabetes
Ayers et al. Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
JP2013518244A5 (https=)
JP2012073260A5 (https=)
WO2012151105A3 (en) Basophil analysis system and method
JP2015505370A5 (https=)
CA2855971C (en) Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
AR088108A1 (es) METODO PARA DETECTAR ANTICUERPOS ESPECIFICOS Ab EN UNA MUESTRA BIOLOGICA
JP2014533372A5 (https=)
JP2017528715A5 (https=)
JP2018528441A5 (https=)
RU2019104870A (ru) Комбинированный тест на наличие колоректального рака
JP2019082446A5 (https=)
JP2014517308A5 (https=)
JP2014512014A5 (https=)
JP2011518338A5 (https=)